Thrombolytic treatment in acute myocardial infarction.
D000800:Angioplasty, Balloon; D016255:Anistreplase; D003331:Coronary Vessels; D004333:Drug Administration Routes; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D010958:Plasminogen / Q000627:therapeutic use; D010960:Plasminogen Activators / Q000627:therapeutic use; D011446:Prospective Studies; D012107:Research Design; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D016255:Anistreplase; D010958:Plasminogen; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator